Woodline Partners’s IGM Biosciences IGMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
|
|||||
|
2025
Q2 | $77.9K | Hold |
|
|||||
|
2025
Q1 | $80K | Buy |
|
|||||
|
2024
Q4 | $411K | Hold |
|
|||||
|
2024
Q3 | $1.11M | Sell |
|
|||||
|
2024
Q2 | $515K | Hold |
|
|||||
|
2024
Q1 | $724K | Hold |
|
|||||
|
2023
Q4 | $623K | Hold |
|
|||||
|
2023
Q3 | $626K | Hold |
|
|||||
|
2023
Q2 | $692K | Sell |
|
|||||
|
2023
Q1 | $2.11M | Buy |
|
|||||
|
2022
Q4 | $2.55M | Sell |
|
|||||
|
2022
Q3 | $4.55M | Hold |
|
|||||
|
2022
Q2 | $3.61M | Sell |
|
|||||
|
2022
Q1 | $10.8M | Hold |
|
|||||
|
2021
Q4 | $11.8M | Sell |
|
|||||
|
2021
Q3 | $37.4M | Sell |
|
|||||
|
2021
Q2 | $62M | Buy |
|
|||||
|
2021
Q1 | $33M | Sell |
|
|||||
|
2020
Q4 | $47.7M | Buy |
|
|||||
|
2020
Q3 | $6.67M | Buy |
|